vs
Cohen & Co Inc.（COHN）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Cohen & Co Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍（$102.7M vs $69.8M），Cohen & Co Inc.同比增速更快（454.1% vs 21.2%），过去两年Cohen & Co Inc.的营收复合增速更高（135.3% vs 53.7%）
科恩父子公司是一家总部位于伦敦商业路的废金属贸易商，由乔治·亨利·科恩于1834年创立，最初名为乔治·科恩公司，1883年创始人之子迈克尔·科恩入职后更名为现名。一战结束后，公司拿下多份大型合同，负责处理包括40万吨烈性炸药及炮弹在内的剩余军火。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
COHN vs RIGL — 直观对比
营收规模更大
COHN
是对方的1.5倍
$69.8M
营收增速更快
COHN
高出432.9%
21.2%
两年增速更快
COHN
近两年复合增速
53.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $102.7M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 29.2% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 454.1% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.77 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COHNRIGL
| Q4 25 | $102.7M | $69.8M | ||
| Q3 25 | $84.2M | $69.5M | ||
| Q2 25 | $59.9M | $101.7M | ||
| Q1 25 | $28.7M | $53.3M | ||
| Q4 24 | $18.5M | $57.6M | ||
| Q3 24 | $31.7M | $55.3M | ||
| Q2 24 | $10.8M | $36.8M | ||
| Q1 24 | $18.6M | $29.5M |
净利润COHNRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $4.6M | $27.9M | ||
| Q2 25 | $1.4M | $59.6M | ||
| Q1 25 | $329.0K | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $2.1M | $12.4M | ||
| Q2 24 | $-2.3M | $-1.0M | ||
| Q1 24 | $2.0M | $-8.2M |
毛利率COHNRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率COHNRIGL
| Q4 25 | 29.2% | 33.2% | ||
| Q3 25 | 25.8% | 40.9% | ||
| Q2 25 | 12.5% | 60.1% | ||
| Q1 25 | 0.4% | 23.9% | ||
| Q4 24 | -29.7% | 28.9% | ||
| Q3 24 | 22.8% | 25.4% | ||
| Q2 24 | -59.0% | 1.2% | ||
| Q1 24 | -18.2% | -23.6% |
净利率COHNRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 5.5% | 40.2% | ||
| Q2 25 | 2.4% | 58.6% | ||
| Q1 25 | 1.1% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 6.8% | 22.5% | ||
| Q2 24 | -21.8% | -2.8% | ||
| Q1 24 | 10.9% | -27.9% |
每股收益（稀释后）COHNRIGL
| Q4 25 | $0.77 | $14.11 | ||
| Q3 25 | $2.58 | $1.46 | ||
| Q2 25 | $0.81 | $3.28 | ||
| Q1 25 | $0.19 | $0.63 | ||
| Q4 24 | $-1.20 | $0.82 | ||
| Q3 24 | $1.31 | $0.70 | ||
| Q2 24 | $-1.47 | $-0.06 | ||
| Q1 24 | $1.28 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $56.8M | $155.0M |
| 总债务越低越好 | $32.9M | $52.5M |
| 股东权益账面价值 | $51.1M | $391.5M |
| 总资产 | $700.6M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.64× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资COHNRIGL
| Q4 25 | $56.8M | $155.0M | ||
| Q3 25 | $54.7M | $137.1M | ||
| Q2 25 | $26.0M | $108.4M | ||
| Q1 25 | $14.0M | $77.1M | ||
| Q4 24 | $19.6M | $77.3M | ||
| Q3 24 | $14.3M | $61.1M | ||
| Q2 24 | $9.6M | $49.1M | ||
| Q1 24 | $11.8M | $49.5M |
总债务COHNRIGL
| Q4 25 | $32.9M | $52.5M | ||
| Q3 25 | $32.7M | $60.0M | ||
| Q2 25 | $32.6M | $60.0M | ||
| Q1 25 | $35.0M | $60.0M | ||
| Q4 24 | $34.9M | $60.0M | ||
| Q3 24 | $34.9M | $60.0M | ||
| Q2 24 | $29.7M | $60.0M | ||
| Q1 24 | $29.7M | $60.0M |
股东权益COHNRIGL
| Q4 25 | $51.1M | $391.5M | ||
| Q3 25 | $47.8M | $117.6M | ||
| Q2 25 | $43.4M | $81.9M | ||
| Q1 25 | $42.0M | $18.6M | ||
| Q4 24 | $41.7M | $3.3M | ||
| Q3 24 | $43.8M | $-14.6M | ||
| Q2 24 | $41.7M | $-29.9M | ||
| Q1 24 | $43.8M | $-31.7M |
总资产COHNRIGL
| Q4 25 | $700.6M | $513.6M | ||
| Q3 25 | $773.9M | $242.5M | ||
| Q2 25 | $1.1B | $206.7M | ||
| Q1 25 | $978.0M | $176.0M | ||
| Q4 24 | $971.1M | $164.0M | ||
| Q3 24 | $818.0M | $139.4M | ||
| Q2 24 | $826.0M | $128.4M | ||
| Q1 24 | $1.1B | $126.5M |
负债/权益比COHNRIGL
| Q4 25 | 0.64× | 0.13× | ||
| Q3 25 | 0.68× | 0.51× | ||
| Q2 25 | 0.75× | 0.73× | ||
| Q1 25 | 0.83× | 3.23× | ||
| Q4 24 | 0.84× | 18.25× | ||
| Q3 24 | 0.80× | — | ||
| Q2 24 | 0.71× | — | ||
| Q1 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | — |
| 自由现金流率自由现金流/营收 | -2.4% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $26.1M | — |
8季度趋势，按日历期对齐
经营现金流COHNRIGL
| Q4 25 | $-2.1M | $22.0M | ||
| Q3 25 | $22.4M | $24.0M | ||
| Q2 25 | $13.3M | $30.5M | ||
| Q1 25 | $-6.4M | $-893.0K | ||
| Q4 24 | $4.4M | $14.5M | ||
| Q3 24 | $4.1M | $21.7M | ||
| Q2 24 | $-4.2M | $302.0K | ||
| Q1 24 | $5.1M | $-5.0M |
自由现金流COHNRIGL
| Q4 25 | $-2.5M | — | ||
| Q3 25 | $22.2M | — | ||
| Q2 25 | $12.9M | — | ||
| Q1 25 | $-6.5M | — | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | $3.8M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $5.0M | — |
自由现金流率COHNRIGL
| Q4 25 | -2.4% | — | ||
| Q3 25 | 26.3% | — | ||
| Q2 25 | 21.6% | — | ||
| Q1 25 | -22.7% | — | ||
| Q4 24 | 21.4% | — | ||
| Q3 24 | 12.0% | — | ||
| Q2 24 | -42.4% | — | ||
| Q1 24 | 27.1% | — |
资本支出强度COHNRIGL
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 0.5% | — |
现金转化率COHNRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 4.88× | 0.86× | ||
| Q2 25 | 9.48× | 0.51× | ||
| Q1 25 | -19.37× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 1.91× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COHN
| Capital Markets | $68.5M | 67% |
| Other | $25.7M | 25% |
| Gestational Repo Business | $5.6M | 5% |
| Asset Management Segment | $2.9M | 3% |
RIGL
暂无分部数据
